Monte Rosa Therapeutics Stock Price on May 9, 2024

GLUE Stock  USD 4.12  0.12  3.00%   
If you're considering investing in Monte Stock, it is important to understand the factors that can impact its price. As of today, the current price of Monte Rosa stands at 4.12, as last reported on the 3rd of June, with the highest price reaching 4.20 and the lowest price hitting 3.90 during the day. Monte Rosa Therapeutics has Sharpe Ratio of -0.0774, which conveys that the firm had a -0.0774% return per unit of risk over the last 3 months. Monte Rosa exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Monte Rosa's Risk Adjusted Performance of (0.04), mean deviation of 4.14, and Standard Deviation of 5.7 to check out the risk estimate we provide.
  
At present, Monte Rosa's Stock Based Compensation is projected to increase significantly based on the last few years of reporting. . At present, Monte Rosa's Price To Book Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Fair Value is expected to grow to 1.70, whereas Price Earnings To Growth Ratio is forecasted to decline to (0.12). Monte Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0774

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsGLUE

Estimated Market Risk

 5.62
  actual daily
49
51% of assets are more volatile

Expected Return

 -0.43
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.08
  actual daily
0
Most of other assets perform better
Based on monthly moving average Monte Rosa is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Monte Rosa by adding Monte Rosa to a well-diversified portfolio.
Price Book
2.0146
Enterprise Value Ebitda
(1.27)
Shares Float
28.6 M
Wall Street Target Price
16
Earnings Share
(2.51)

Monte Rosa Main Headline on 9th of May 2024

GLUE stock results show that Monte Rosa Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Monte Rosa Valuation on May 9, 2024

It is possible to determine the worth of Monte Rosa on a given historical date. On May 9, 2024 Monte was worth 5.24 at the beginning of the trading date compared to the closed value of 5.18. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Monte Rosa stock. Still, in general, we apply an absolute valuation method to find Monte Rosa's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Monte Rosa where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Monte Rosa's related companies.
 Open High Low Close Volume
  5.61    5.69    5.17    5.26    137,485  
05/09/2024
  5.24    5.30    5.09    5.18    241,170  
  5.22    5.24    4.63    4.85    150,312  
Backtest Monte Rosa  |  Monte Rosa History  |  Monte Rosa Valuation   PreviousNext  
Open Value
5.24
5.18
Closing Value
22.10
Upside

Monte Rosa Trading Date Momentum on May 9, 2024

On May 10 2024 Monte Rosa Therapeutics was traded for  4.85  at the closing time. The top price for the day was 5.24  and the lowest listed price was  4.63 . The trading volume for the day was 150.3 K. The trading history from May 10, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 6.37% . The trading delta at closing time against the current closing price is 0.00% .

Monte Rosa Therapeutics Fundamentals Correlations and Trends

By evaluating Monte Rosa's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Monte Rosa's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Monte financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Monte Rosa Stock history

Monte Rosa investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Monte is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Monte Rosa Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Monte Rosa stock prices may prove useful in developing a viable investing in Monte Rosa
Last ReportedProjected for Next Year
Common Stock Shares Outstanding51.4 M51.3 M
Net Loss-97.7 M-102.5 M

Monte Rosa Quarterly Net Working Capital

157.74 Million

Monte Rosa Stock Technical Analysis

Monte Rosa technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Monte Rosa technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Monte Rosa trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Monte Rosa Period Price Range

Low
May 9, 2024
-0.06  -1.15%
High

 5.24 

     

 5.18 

Monte Rosa June 3, 2024 Market Strength

Market strength indicators help investors to evaluate how Monte Rosa stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Monte Rosa shares will generate the highest return on investment. By undertsting and applying Monte Rosa stock market strength indicators, traders can identify Monte Rosa Therapeutics entry and exit signals to maximize returns

Monte Rosa Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Monte Rosa's price direction in advance. Along with the technical and fundamental analysis of Monte Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Monte to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Monte Rosa Therapeutics is a strong investment it is important to analyze Monte Rosa's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Monte Rosa's future performance. For an informed investment choice regarding Monte Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Monte Rosa Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Complementary Tools for Monte Stock analysis

When running Monte Rosa's price analysis, check to measure Monte Rosa's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Monte Rosa is operating at the current time. Most of Monte Rosa's value examination focuses on studying past and present price action to predict the probability of Monte Rosa's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Monte Rosa's price. Additionally, you may evaluate how the addition of Monte Rosa to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Transaction History
View history of all your transactions and understand their impact on performance
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Commodity Directory
Find actively traded commodities issued by global exchanges
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Is Monte Rosa's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Monte Rosa. If investors know Monte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Monte Rosa listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.51)
Revenue Per Share
0.02
Return On Assets
(0.31)
Return On Equity
(0.68)
The market value of Monte Rosa Therapeutics is measured differently than its book value, which is the value of Monte that is recorded on the company's balance sheet. Investors also form their own opinion of Monte Rosa's value that differs from its market value or its book value, called intrinsic value, which is Monte Rosa's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Monte Rosa's market value can be influenced by many factors that don't directly affect Monte Rosa's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Monte Rosa's value and its price as these two are different measures arrived at by different means. Investors typically determine if Monte Rosa is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Monte Rosa's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.